Jay Cross
Financieel Directeur/CFO bij SONNET BIOTHERAPEUTICS HOLDINGS, INC.
Vermogen: 1 707 $ op 31-05-2024
Profiel
John Harry Cross is currently the Chief Financial & Business Officer at Sonnet BioTherapeutics, Inc. and Sonnet BioTherapeutics Holdings, Inc. He previously worked as the Managing Director-Healthcare Investment Banking at Chardan Capital Markets LLC and as a Director at Alere Financial Partners.
He received his undergraduate degree from Washington & Lee University and his graduate degree from Yale School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-12-2023 | 1 087 ( 0.03% ) | 1 707 $ | 31-05-2024 |
Actieve functies van Jay Cross
| Bedrijven | Functie | Begin |
|---|---|---|
| SONNET BIOTHERAPEUTICS HOLDINGS, INC. | Financieel Directeur/CFO | 01-05-2019 |
Sonnet BioTherapeutics, Inc.
 Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | Financieel Directeur/CFO | 01-05-2019 |
Eerdere bekende functies van Jay Cross
| Bedrijven | Functie | Einde |
|---|---|---|
Chardan Capital Markets LLC
 Chardan Capital Markets LLC Investment Banks/BrokersFinance Chardan Capital Markets LLC is a registered broker-dealer headquartered in New York City. The firm was founded by Kerry Propper and Steve Urbach in 2003. The firm offers a range of services which include capital raising, merger and acquisition advisory, strategic advisory, equity research, corporate access and institutional trading to institutional clients. | Corporate Officer/Principal | 01-03-2019 |
Alere Financial Partners
 Alere Financial Partners Investment ManagersFinance Alere Financial Partners provides investment research. The private company is based in King of Prussia, PA. | Directeur/Bestuurslid | 01-06-2015 |
Opleiding van Jay Cross
| Washington & Lee University | Undergraduate Degree |
| Yale School of Medicine | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SONNET BIOTHERAPEUTICS HOLDINGS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Chardan Capital Markets LLC
Chardan Capital Markets LLC Investment Banks/BrokersFinance Chardan Capital Markets LLC is a registered broker-dealer headquartered in New York City. The firm was founded by Kerry Propper and Steve Urbach in 2003. The firm offers a range of services which include capital raising, merger and acquisition advisory, strategic advisory, equity research, corporate access and institutional trading to institutional clients. | Finance |
Alere Financial Partners
Alere Financial Partners Investment ManagersFinance Alere Financial Partners provides investment research. The private company is based in King of Prussia, PA. | Finance |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | Health Technology |
